DuoBody®
Showing 1 - 25 of >10,000
Diffuse Large B Cell Lymphoma Trial (Epcoritamab, Lenalidomide)
Not yet recruiting
- Diffuse Large B Cell Lymphoma
- Epcoritamab
- Lenalidomide
- (no location specified)
Jan 20, 2023
Large B-cell Lymphoma, DLBCL, Not Otherwise Specified, Primary Mediastinal Large B-cell Lymphoma (PMBCL) Trial (Epcoritamab)
Available
- Large B-cell Lymphoma
- +4 more
- Epcoritamab
- (no location specified)
Feb 16, 2023
Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, Primary Mediastinal Large B Cell Lymphoma Trial in Japan (epcoritamab
Recruiting
- Diffuse Large B Cell Lymphoma
- +5 more
- epcoritamab (monotherapy)
- +5 more
-
Chuo Ku, Japan
- +19 more
Nov 22, 2022
Malignant Solid Tumor Trial (GEN1042, Pembrolizumab, Cisplatin)
Not yet recruiting
- Malignant Solid Tumor
- GEN1042
- +4 more
- (no location specified)
Sep 21, 2023
Classical Hodgkin Lymphoma, Non-Hodgkin Lymphoma Trial (GEN3017)
Not yet recruiting
- Classical Hodgkin Lymphoma
- Non-Hodgkin Lymphoma
- GEN3017
- (no location specified)
Aug 25, 2023
Follicular Lymphoma, Low Grade Non-Hodgkin's Lymphoma, Adult Trial in Boston (Epcoritamab, Rituximab)
Not yet recruiting
- Follicular Lymphoma
- Low Grade Non-Hodgkin's Lymphoma, Adult
-
Boston, MassachusettsDana-Farber Cancer Institute
Mar 13, 2023
Solid Tumor Trial in Tokyo (GEN1046)
Recruiting
- Solid Tumor
- GEN1046
-
Tokyo, Japan
- +1 more
Jan 13, 2023
Non-CNS Tumor Trial (biological, drug, radiation)
Not yet recruiting
- Non-CNS Tumor
- GEN1042
- +2 more
- (no location specified)
Aug 4, 2022
Breast Cancer, Uterine Cancer, Ovarian Cancer Trial in Denmark, France, Spain (GEN1047 is a bispecific antibody that induces
Recruiting
- Breast Cancer
- +3 more
- GEN1047 is a bispecific antibody that induces T-cell mediated cytotoxicity of B7H4-positive cells.
-
Copenhagen, Denmark
- +5 more
Jul 25, 2022
Relapsed/Refractory Chronic Lymphocytic Leukemia, Richter's Syndrome Trial in Worldwide (Epcoritamab)
Recruiting
- Relapsed/Refractory Chronic Lymphocytic Leukemia
- Richter's Syndrome
- Epcoritamab
-
Tuscaloosa, Alabama
- +22 more
Jun 15, 2022
Follicular Lymphoma Trial in Duarte, Irvine (procedure, other, biological, drug)
Not yet recruiting
- Follicular Lymphoma
- Biospecimen Collection
- +7 more
-
Duarte, California
- +1 more
Oct 27, 2023
Dose Escalation Part: Locally Advanced or Metastatic Solid Tumor(s), Expansion Part: Prostate Cancer, Expansion Part: Esophageal
Terminated
- Dose Escalation Part: Locally Advanced or Metastatic Solid Tumor(s)
- +7 more
- GEN1044 is an IgG1 bispecific antibody targeting CD3 and 5T4.
-
Nashville, Tennessee
- +5 more
Mar 1, 2022
DLBCL, Follicular Lymphoma Trial in Worldwide (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone, rituximab
Recruiting
- Diffuse Large B-Cell Lymphoma
- Follicular Lymphoma
- rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone
- +7 more
-
Birmingham, Alabama
- +61 more
Apr 13, 2022
Non Small Cell Lung Cancer Metastatic Trial in Worldwide (GEN1046, Pembrolizumab)
Recruiting
- Non Small Cell Lung Cancer Metastatic
- GEN1046
- Pembrolizumab
-
Santa Rosa, California
- +26 more
Jan 30, 2023
Diffuse Large B-cell Lymphoma, Follicular Lymphoma, Marginal Zone Lymphoma Trial in Worldwide (GEN3009, Epcoritamab)
Recruiting
- Diffuse Large B-cell Lymphoma
- +7 more
- GEN3009
- Epcoritamab
-
Tucson, Arizona
- +31 more
Jul 1, 2022
Diffuse Large B-cell Lymphoma Trial in Worldwide (Epcoritamab, Investigator's Choice Chemotherapy)
Recruiting
- Diffuse Large B-cell Lymphoma
- Epcoritamab
- Investigator's Choice Chemotherapy
-
Irvine, California
- +254 more
Jan 9, 2023
Atrial Fibrillation Trial in Genk (Heart rhythm measurements with Preventicus®, Heart rhythm measurements with FibriCheck®,
Recruiting
- Atrial Fibrillation
- Heart rhythm measurements with Preventicus®
- +3 more
-
Genk, Limburg, BelgiumZiekenhuis Oost-Limburg
Aug 28, 2023
ECMO Braile Biomédica® in COVID-19 Patients
Recruiting
- COVID-19
- Patients underwent cardiorespiratory support
-
Lago Sul, Brasília - DF, BrazilHospital Brasília
Oct 13, 2023
Metastatic Gastric Adenocarcinoma, Second Line, Chemo Trial (nal-IRI /Experimental, Ramucirumab /Experimental,
Not yet recruiting
- Metastatic Gastric Adenocarcinoma
- +2 more
- nal-IRI /Experimental
- +2 more
- (no location specified)
Jun 25, 2023
Venous Leg Ulcer, Diabetic Foot Trial in Worldwide (AQUACEL® Ag+ Extra™, Cutimed® Sorbact®)
Recruiting
- Venous Leg Ulcer
- Diabetic Foot
- AQUACEL® Ag+ Extra™
- Cutimed® Sorbact®
-
Barranquilla, Colombia
- +13 more
May 26, 2023
Dental Implants Trial in L´hospitalet de Llobregat (Dynamic Computer Assisted Surgery, Freehand)
Recruiting
- Dental Implants
- Dynamic Computer Assisted Surgery
- Freehand
-
L´hospitalet de Llobregat, Catalunya, SpainUniversity of Barcelona
Aug 31, 2023
Carpal Tunnel Syndrome Trial in Denizli (KForce Sens, Baseline Electrigoniometer)
Completed
- Carpal Tunnel Syndrome
- KForce Sens
- Baseline Electrıgoniometer
-
Denizli, TurkeyPamukkale University
Sep 14, 2023
Tricuspid Regurgitation, Tricuspid Valve Disease Trial in Worldwide (TricValve® Transcatheter Bicaval Valve System, Medical
Not yet recruiting
- Tricuspid Regurgitation
- Tricuspid Valve Disease
- TricValve® Transcatheter Bicaval Valve System
- Medical Therapy Arm
-
Cleveland, Ohio
- +10 more
Nov 14, 2023